Your browser doesn't support javascript.
loading
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M).
Aravind, S R; Singh, Kiran P; Aquitania, Grace; Mogylnytska, Liliia; Zalevskaya, Alsu G; Matyjaszek-Matuszek, Beata; Wernicke-Panten, Karin; Nguyên-Pascal, My-Liên; Pierre, Suzanne; Rotthaeuser, Baerbel; Kramer, Daniel; Mukherjee, Bhaswati.
Afiliación
  • Aravind SR; Diabetes Care and Research Center, Diacon Hospital, Bangalore, India.
  • Singh KP; Columbia Asia Hospital, Bangalore, India.
  • Aquitania G; Department of Endocrinology, Fortis Hospital Mohali, Chandigarh, India.
  • Mogylnytska L; Davao Doctors Hospital, Davao City, Philippines.
  • Zalevskaya AG; Khmelnytskyi Regional Hospital, Khmelnytskyi, Ukraine.
  • Matyjaszek-Matuszek B; Department of Endocrinology, First Pavlov State Medical University, St. Petersburg, Russia.
  • Wernicke-Panten K; Department of Endocrinology, Medical University of Lublin, Lublin, Poland.
  • Nguyên-Pascal ML; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
  • Pierre S; Sanofi-Aventis Research and Development, Chilly-Mazarin, France.
  • Rotthaeuser B; Sanofi-Aventis Research and Development, Chilly-Mazarin, France.
  • Kramer D; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
  • Mukherjee B; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
Diabetes Ther ; 13(5): 1053-1071, 2022 May.
Article en En | MEDLINE | ID: mdl-35420397

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Diabetes Ther Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Diabetes Ther Año: 2022 Tipo del documento: Article País de afiliación: India